Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2007
12/19/2007EP1867719A2 Methods and compositions for inhibiting neoplastic cell growth
12/19/2007EP1867661A1 Compositions and methods for delivering anti-activated ras antibodies into cells
12/19/2007EP1867659A1 Antibody reactive specifically to age derived from 3,4-dge
12/19/2007EP1866647A1 A method of diagnosis and treatment and agents useful for same
12/19/2007EP1866340A1 Immunoglobulin fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same
12/19/2007EP1866339A2 Gitr binding molecules and uses therefor
12/19/2007EP1866338A1 Antibodies against cd38 for treatment of multiple myeloma
12/19/2007EP1866337A1 Method for obtaining antibodies
12/19/2007EP1866336A2 Neutralizing antibodies and methods of use thereof
12/19/2007EP1865986A2 Anti-ctla-4 antibody compositions
12/19/2007EP1865985A2 Kim-1 antibodies for treatment of th2-mediated conditions
12/19/2007EP1865952A1 Histamine-containing composition for the treatment of allergic diseases
12/19/2007EP1416965B1 Assay method for alzheimer's disease
12/19/2007EP1282822B1 Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen
12/19/2007EP1230369B1 Polypeptide hormone phosphatonin
12/19/2007EP1090033B2 Particles of hcv envelope proteins: use for vaccination
12/19/2007EP0652950B1 Generation of xenogeneic antibodies
12/19/2007EP0519001B2 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
12/19/2007CN101090913A Antibodies against tenascin-c
12/19/2007CN101090729A Antibodies and related molecules that bind to psca proteins
12/19/2007CN101088561A Anti hepatitis c virus antibody and uses thereof
12/19/2007CN100355882C Hybridoma cell strain and its produced human VEGFR-3 resistant monoclonal antibody
12/19/2007CN100355785C Process for selectively separating IgY antibody from anseriforme birds eggs and IgY antibody produced therefrom
12/19/2007CN100355782C New liver cancer up expressing gene and its encoded protein and application
12/18/2007US7309780 Antibodies to natural killer cell activating factor II
12/18/2007US7309779 Male reproductive disorders including proliferative disorders of testes
12/18/2007US7309778 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/18/2007US7309777 Antibodies against the PRO1556 polypeptide
12/18/2007US7309776 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders
12/18/2007US7309775 Membrane binding protein; central nervous system disorders, Alzheimer's disease, Parkinson's disease
12/18/2007US7309771 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
12/18/2007US7309768 PRO4347 polypeptides
12/18/2007US7309767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
12/18/2007US7309765 PRO4349 polypeptides
12/18/2007US7309764 PRO4401 polypeptide
12/18/2007US7309763 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
12/18/2007US7309760 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
12/18/2007US7309759 Indolicidin peptide analogues containing at least two basic amino acids; bactericide
12/18/2007US7309694 Gene therapy; cytokine complex; anticancer agent
12/18/2007US7309693 Comprises antagonistic mutein of MCP-1 (monocyte chemoattractant protein-1: macrophage chemotactic factor)
12/18/2007US7309600 Haemophilus influenzae sialyltransferase and methods of use thereof
12/18/2007US7309584 Mutations of the MDR1 P-glycoprotein that improves its ability to confer resistance to chemotherapeutic drugs
12/18/2007US7309583 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infection of mammals
12/18/2007US7309578 Administering an antagonist inhibiting apoptosis of lung cells, diagnosing the disease
12/18/2007US7309566 Using biotinylated single chain fragment of variable antibodyies to detect and prevent viral infection.
12/18/2007US7309494 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; diagnostic kits for respiratory syncytial virus
12/18/2007US7309492 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus
12/18/2007US7309490 Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
12/18/2007US7309485 Oligodendrocyte-myelin glycoprotein (OMgp)-specific binding agents, receptor binding assays; promoting nerve fiber growth
12/18/2007CA2233042C Specific binding members for human transforming growth factor beta; materials and methods
12/18/2007CA2179562C Peptide useful in the separation and purification of immunoglobulins
12/18/2007CA2062047C Fusion proteins for prodrug activation, the preparation and use thereof
12/18/2007CA1341566C Immune response to tumors induced by anti-idiotype antibodies
12/13/2007WO2007143701A2 Monoclonal antibodies that potently neutralize hepatitis c virus (hcv) of diverse genotypes
12/13/2007WO2007143168A2 High affinity antibodies to human il-6 receptor
12/13/2007WO2007143121A2 Purification of a bivalently active antibody using a non-chromatographic method
12/13/2007WO2007143098A2 Hepatocyte growth factor (hgf) binding proteins
12/13/2007WO2007142578A1 Method of separating monomeric protein (s)
12/13/2007WO2007142336A1 Gene involved in immortalization of human cancer cell and use thereof
12/13/2007WO2007142325A1 Preventive or remedy for inflammatory disease
12/13/2007WO2007142277A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
12/13/2007WO2007142276A1 Method for determination of secreted heparin-binding epidermal growth factor-like growth factor
12/13/2007WO2007142258A1 Anthocyanin synthesis regulatory gene, and use thereof
12/13/2007WO2007142241A1 Immunocompetent cell having anti-cd38 antibody on its cell surface
12/13/2007WO2007142223A1 Method for diagnosis of hepatocellular carcinoma
12/13/2007WO2007141971A1 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity
12/13/2007WO2007141278A2 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
12/13/2007WO2007141274A2 Human binding molecules having killing activity against staphylococci and uses thereof
12/13/2007WO2007141043A2 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma
12/13/2007WO2007141029A1 Specific protease inhibitors and their use in cancer therapy
12/13/2007WO2007140953A1 Peptide associated with rheumatic fever (parf) and its use as a diagnostic marker
12/13/2007WO2007140739A2 Apparatus and method for the subfractionation of an antibody mixed population directed against a polypeptide, together with plug-in mounting system
12/13/2007WO2007140618A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease
12/13/2007WO2007140545A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefore
12/13/2007WO2007140534A1 Vegf-a cross-reactive anti- vegf-b antibodies as antagonists of vegf-a and vegf-b signalling
12/13/2007WO2007108559A8 Agonistic antibody directed against human thrombopoietin receptor
12/13/2007WO2007104529A3 Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
12/13/2007WO2007084105A3 Modulation of fc gamma receptors for optimizing immunotherapy
12/13/2007WO2007067557A3 Methods for cyclic nucleotide determination
12/13/2007WO2007067512A3 Method for identifying modulators of adprh useful for treating alzheimer's disease
12/13/2007WO2007065433A3 Anti-orthopoxvirus recombinant polyclonal antibody
12/13/2007WO2007008943A3 Optimized anti-ep-cam antibodies
12/13/2007WO2006138737A8 Methods of purifying anti a beta antibodies
12/13/2007WO2006115548A3 Subunit vaccine against west nile viral infection
12/13/2007WO2006076687A3 Elisa assays using prion-specific peptide reagents
12/13/2007WO2006076255A3 Method of treating or preventing microbial eye infection
12/13/2007WO2005067486A3 Quantitative protein assay using single affinity capture agent for identification and detection
12/13/2007WO2005017103A3 Bacterial nitric oxide synthases and uses thereof
12/13/2007US20070287825 Constrained cis-diol-borate bioconjugation system
12/13/2007US20070287676 Diagnosis and treatment of endometriosis
12/13/2007US20070287668 Methods, kits, and antibodies for detecting parathyroid hormone
12/13/2007US20070287667 Chimpanzee monoclonal antibodies and antigen binding fragments including variable region peptides; bioassay for detection of hepatitis A virus; diagnosis, treatment and prevention of hepatitis; kits
12/13/2007US20070287177 Bonding to monoclonal antibodies; antitumor agents
12/13/2007US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders
12/13/2007US20070287170 Engineered heterodimeric protein domains
12/13/2007US20070287163 Methods for Diagnosis of Acute Myeloid Leukemia
12/13/2007US20070286874 Recombinant attenuated clostridium organisms and vaccine
12/13/2007US20070286869 Influenza virus vaccine composition and methods of use
12/13/2007US20070286868 Phosphorylcholine Conjugates and Corresponding Antibodies
12/13/2007US20070286866 Compositions For Reducing Bacterial Carriage And Cnc Invasion And Methods Of Using Same